Susana Hernández-García

Sox2 expression in breast tumours and activation in breast cancer stem cells

Olatz Leis, Arrate Eguiara, Erika López‐Arribillaga et al. · Oncogene · 2011 · 522 citations

Medicine, Cancer Biology, Oncology +16

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

Esperanza M. Algarín, Andrea Díaz-Tejedor, Pedro Mogollón et al. · Haematologica · 2019 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

Teresa Paíno, Antonio García-Gómez, Lorena González-Méndez et al. · Clinical Cancer Research · 2016 · 55 citations · Full text

Medicine, Oncology, Pharmacology +15

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

Ana-Alicia López-Iglesias, Ana B. Herrero, Marta Chesi et al. · Journal of Hematology & Oncology · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

Susana Hernández-García, Laura San‐Segundo, Lorena González-Méndez et al. · Haematologica · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16